Novasep invests EUR 30 million to build world's largest chromatography plant for the pharmaceutical industry

New plant on its Mourenx, France site to produce a large volume commercial API

15-Oct-2012 - Novasep announced an investment of EUR 30 million to build in Europe what will be the world's largest chromatography plant used for the production of a large volume commercial API (active pharmaceutical ingredient).The plant will be built on Novasep's existing Mourenx site in France and will be ...

Dionex Demonstrates Simplified Determination of 2-Ethylhexanoic Acid in Clavulanate

27-Oct-2010 - Dionex announced a simplified method for the detection and quantification of 2-ethylhexanoic acid, a potential impurity in potassium clavulanate active pharmaceutical ingredient (API) incorporated during sample purification. Application Note 262: Determination of 2-Ethylhexanoic Acid Impurity in ...

Novasep and instrAction enter a worldwide strategic alliance for non-chiral chromatography

21-Jul-2010 - Novasep and instrAction announced that they have entered a strategic alliance. The alliance will offer customers in the life science industry a combination of instrAction’s proprietary API-selective stationary phases (Instruction® Receptor Phase) and Novasep purification capabilities and high ...

Novasep appoints two key executives

Stephen Stefano heads up Novasep North American business and Patrick Glaser leads Novasep Synthesis division

05-May-2010 - Novasep announced the appointments of two highly experienced managers in its drive to grow the group’s US presence and develop its Novasep Synthesis division. Stephen F. Stefano becomes President and CEO of Novasep North American business, and Patrick A. Glaser President and CEO of the Novasep ...

Stratophase heads £1.2m project to develop real-time high value liquid monitoring systems

03-Mar-2010 - Stratophase announced that, as part of a consortium of companies, it is developing a cost-effective, multi-parametric, multi-point, in-line sensor system for high-value liquid production processes. Utilising Stratophase's advanced SpectroSens optical microchip technology, this £1.2m project will ...

AMRI Names Senior Director, Analytical and Quality Services

14-Jan-2009 - AMRI announced that Junan Guo, Ph.D. has joined the company as senior director, analytical and quality services. Dr. Guo fills the role vacated by Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008. Dr. Guo will oversee all ...

New laser technique promises better process control in the pharmaceutical industry

20-Feb-2008 - Scientists at the Science and Technology Facilities Council (STFC) Rutherford Appleton Laboratory in Oxfordshire, UK have developed an effective laser based method for the characterisation of the bulk chemical content of pharmaceutical capsules - without opening the capsules. In close ...

Buchwald wins Siegfried Medal from University of Zurich

30-Aug-2006 - The University of Zurich and Siegfried Ltd announced that Professor Stephen L. Buchwald of Massachusetts Institute of Technology will receive the 2006 Siegfried Medal for his achievements in process chemistry. Professor Buchwald's contributions have effected process chemistry primarily in the ...

Merck Sharp & Dohme Expands Singapore Facility with S$100 Million Investment

31-Jul-2006 - MSD Technology Singapore Pte Ltd., a wholly owned subsidiary of Merck & Co. dedicated an expansion of its production facilities in Singapore. The expanded facilities are scheduled to open in the fourth quarter of 2006. Now in the final stages of construction, the expansion consists of ...

Sigma-Aldrich Acquires Iropharm to Expand cGMP Capacity

05-May-2006 - Sigma-Aldrich Corporation announced that it has acquired Honeywell International's Iropharm unit, a custom chemical synthesis business located in Arklow, Ireland. The addition of Iropharm will substantially increase SAFC's active pharmaceutical ingredient (API) and pharmaceutical intermediates ...